The nation of Zimbabwe has declined a major US healthcare agreement valued at 367 million US dollars (£272m) spanning five years over Washington's request for sensitive biological samples.
This move came to light following a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesman later clarified that the United States was seeking genetic material for research and profit while was unwilling to guarantee the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged further talks to secure a deal acceptable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Implications
This rejection comes after a similar situation in Kenya, where a high court halted a related health funding agreement following concerns were filed about the security of Kenyans' medical information.
After returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral deals to boost openness and accountability.
Based on reports, Sixteen nations in Africa have so far signed similar agreements, representing over $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy through American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to provide its genetic material and health information indefinitely, with no corresponding promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"Put simply, our country would provide the basic resources for medical research without any certainty that the end products would be accessible to our citizens should a future health crisis emerge."
Sovereignty and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting structures already set up through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to deal with potential pandemics.
"This mechanism is intended to ensure that when a country provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We are open to further dialogue with our US partners on how subsequent co-operation might be designed in a way that honours the sovereignty and interests of each country."
Medical Community Response
A leading public health body said it recognised the government's concerns, but suggested that negotiations need to persist given that much of the country's Aids initiatives were funded by external financing.
"In cases where technical issues exist, including those involving information security or implementation frameworks, these can frequently be resolved via detailed discussion and mutually agreed protections," it commented.
This impasse highlights the complex tensions between accepting much-needed international aid and protecting a country's data in an increasingly interconnected world.